Michael J. M. Hitchcock

Statistics

Publications

Citations

3.6K

H-Index

Active since

1976

Affiliations

Bristol-Myers Squibb (United States)(Current)

Gilead Sciences (United States)

University of Alabama at Birmingham

Georgetown University

National Institutes of Health

Michael J. M. Hitchcock is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, antiviral pharmacology, and antiviral agents.

ORCID

Publications per year

1976–2021

Publications

Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors

Gabriel Birkuš, Michael J. M. Hitchcock, Tomáš Cihlář · Antimicrobial Agents and Chemotherapy · 2002 · 441 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent

Muzammil M. Mansuri, John E. Starrett, Ismail Ghazzouli et al. · Journal of Medicinal Chemistry · 1989 · 212 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

K C Cundy, Brent G. Petty, John F. Flaherty et al. · Antimicrobial Agents and Chemotherapy · 1995 · 204 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Cellular pharmacology of 2',3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus

H T Ho, Michael J. M. Hitchcock · Antimicrobial Agents and Chemotherapy · 1989 · 197 citations · Full text

Life Sciences, Biochemistry, Pharmacology +11

Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.

H.-T. Ho, Kathleen L. Woods, Joanne J. Bronson et al. · Molecular Pharmacology · 1992 · 188 citations

Life Sciences, Biochemistry, Pharmacology +10

1–5 of 56